HEALIUS LIMITED — Capital/Financing Update 2018

Sep 11, 2018

ASX Announcement (ASX: PRY)

ASX Limited Market Announcements Office Exchange Centre Level 4, 20 Bridge Street Sydney NSW 2000

==> picture [134 x 39] intentionally omitted <==

ACN 064 530 516 REGISTERED OFFICE: LEVEL 6 203 PACIFIC HIGHWAY ST LEONARDS NSW 2065 TEL: +61 2 9432 9400 FAX: +61 2 9432 9447

12 September 2018

NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES

PRIMARY SUCCESSFULLY COMPLETES RETAIL ENTITLEMENT OFFER

Primary Health Care (ASX: PRY) (" Primary ") is pleased to announce the successful completion of the retail component (“ Retail Entitlement Offer ”) of its 1 for 5.21 accelerated pro rata non-renounceable entitlement offer of new shares in Primary (“ New Shares ”) announced on 20 August 2018 (“ Entitlement Offer ”).

The Retail Entitlement Offer closed at 5.00pm (Sydney time) on Friday, 7 September 2018 and raised a total of approximately $94 million at $2.50 per share (“ Offer Price ”). This follows the successful completion of the institutional component of the Entitlement Offer which raised approximately $157 million.

Approximately 9 million New Shares that were not taken up under the Retail Entitlement Offer will be acquired by the underwriters or sub-underwriters at the Offer Price in accordance with the terms of the underwriting and sub-underwriting agreements.

New Shares issued under the Retail Entitlement Offer will rank equally with existing shares but will not qualify for the FY 2018 final dividend. The New Shares issued under the Retail Entitlement Offer are expected to be allotted on Friday, 14 September 2018. Trading will commence on a normal settlement basis on the Australian Securities Exchange (“ ASX ”) on Monday, 17 September 2018.

Important information

Nothing contained in this announcement constitutes investment, legal, tax or other advice. You should make your own assessment and take independent professional advice in relation to the information and any action on the basis of the information.

ENDS

For further information contact: Janet Payne Group Executive, Corporate Affairs Phone: +61 2 9432 9512 Mobile: +61 409 995 517

Katie Pearson Manager, Corporate Affairs Phone: +61 2 9432 9599 Mobile: +61 435 652 967

1

For over 30 years Primary Health Care has been one of Australia’s leading listed healthcare companies with a commitment to supporting quality, affordable and accessible healthcare for all Australians. Through an expansive network of multi-disciplinary medical centres, pathology laboratories and diagnostic imaging centres, Primary provides world class facilities and support services to independent GPs, radiologists, specialists and other healthcare practitioners, enabling them to deliver quality care to patients in partnership with Primary’s pathologists, nurses and other employees. Primary’s ‘medical home’ model makes healthcare services easily accessible and cost efficient, while enabling the coordination and continuity of patient care.

Not for release or distribution in the United States

This announcement has been prepared for publication in Australia and may not be released or distributed in the United States. This announcement does not constitute an offer, invitation or recommendation to subscribe for or purchase any security or financial product and neither this announcement nor anything attached to this announcement shall form the basis of any contract or commitment. In particular, this announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States or any other jurisdiction in which such an offer would be illegal. Neither the entitlements nor the new shares have been, or will be, registered under the U.S. Securities Act of 1933, as amended (“U.S. Securities Act”) or the securities laws of any state or other jurisdiction of the United States. Accordingly, the entitlements may not be exercised or taken up by, and the new shares may not be offered or sold, directly or indirectly, to persons in the United States unless they have been registered under the U.S. Securities Act (which Primary has no intention or obligation to do or procure) or are offered and sold pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and any other applicable securities laws of any state or other jurisdiction of the United States.

2